Cargando…

Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Padhi, Srikant, Kumar, Vinod
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2019
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324157/ https://www.ncbi.nlm.nih.gov/pubmed/30574948 http://dx.doi.org/10.4103/ijo.IJO_1740_18

Ejemplares similares

Response to comment on: Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
por: Padhi, Srikant, et al.
Publicado: (2019)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Samanta, Ramanuj
Publicado: (2019)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Tripathy, Koushik, et al.
Publicado: (2019)

Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
por: Padhy, Srikant, et al.
Publicado: (2018)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Raizada, Seemant, et al.
Publicado: (2011)

Intravitreal bevacizumab
por: Khamar, Bakulesh M
Publicado: (2018)

Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity”
por: Samanta, Ramanuj
Publicado: (2019)

Decompression retinopathy after intravitreal bevacizumab and anterior chamber paracentesis in a patient with neovascular glaucoma
por: Kim, Eung Suk, et al.
Publicado: (2016)

Comment on: An unusual presentation of nonarteritic ischemic optic neuropathy with subretinal fluid treated with intravitreal bevacizumab
por: Kalamkar, Charudutt, et al.
Publicado: (2016)

Severe epistaxis related to intravitreal bevacizumab
por: Otten, Leila S., et al.
Publicado: (2019)

Response to comment on “Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment”
por: Storch, Marcus, et al.
Publicado: (2018)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus
por: Joob, Beuy, et al.
Publicado: (2017)

Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2014)

Intravitreal bevacizumab monotherapy for treatment-naïve polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2013)

Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
por: Shah, Parag K, et al.
Publicado: (2011)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
por: Al-Hinai, Ahmed S.
Publicado: (2012)

Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy
por: Tan, Colin S H, et al.
Publicado: (2013)

Paralytic ileus after bilateral intravitreal injection of bevacizumab
por: Kim, Young Gyun, et al.
Publicado: (2016)

Response to comments on: Smartphone-based fundus documentation in retinopathy of prematurity
por: Goyal, Anubhav, et al.
Publicado: (2019)

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization
por: Chhablani, Jay Kumar
Publicado: (2010)

Response to comment on: Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
por: Ranjan, Richa, et al.
Publicado: (2018)

Response to comments on: Real-life comparison of three intravitreal antibiotic drug regimens in endophthalmitis
por: Bari, Aafreen, et al.
Publicado: (2022)

Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy
por: Mandal, Subrata, et al.
Publicado: (2011)

Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane
por: Shanmugam, Mahesh P, et al.
Publicado: (2007)

Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion‐related macular oedema: A prospective randomized comparison—Comment
por: Wen, Dejia, et al.
Publicado: (2019)

Response to comment on “Impact of expansion of telemedicine screening for retinopathy of prematurity in India”
por: Vinekar, Anand, et al.
Publicado: (2018)

Response to comments on: Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema
por: Mahapatra, Santosh Kumar, et al.
Publicado: (2021)

Response to comments on: Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema
por: Mahapatra, Santosh Kumar, et al.
Publicado: (2021)

Comment on: “Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment”
por: Tripathy, Koushik
Publicado: (2018)

Analyzing the role of intravitreal bevacizumab and pars plana vitrectomy in nontractional refractory diabetic macular edema
por: Dubey, Arvind Kumar, et al.
Publicado: (2016)

Urethral caruncle in a perimenopausal female: Dramatic response to topical estrogen cream
por: Balai, Manisha, et al.
Publicado: (2018)

Combined Intravitreal Bevacizumab And Dexamethasone In Bilateral Lupus Retinopathy
por: Shrestha, Ruchi, et al.
Publicado: (2019)

Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain
por: Obata, Shumpei, et al.
Publicado: (2021)

Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy
por: Mandal, Subrata, et al.
Publicado: (2011)

Non-arteritic ischemic optic neuropathy followed by intravitreal bevacizumab injection: Is there an association?
por: Bodla, Ali A, et al.
Publicado: (2010)

Pneumatic displacement and intravitreal bevacizumab for management of submacular hemorrhage in choroidal neovascular membrane
por: Agarwal, Manisha, et al.
Publicado: (2010)

Retinal pigment epithelial tear after intravitreal bevacizumab injection for exudative age-related macular degeneration
por: Singh, Sunil Kumar, et al.
Publicado: (2014)

Response of Diabetic Papillopathy to Intravitreal Bevacizumab
por: Al-Dhibi, Hassan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fk9c12oekjku5vukvu86jilbpc